Its side effect profile is generally favorable compared to many other anti-obesity medications due to its more targeted mechanism of action and pharmacological properties
Conclusion By focusing on the ROS-related PIPN mechanism, both antioxidant drugs (e.g., small molecular drugs, traditional medicines/active ingredients) and tailor-made nanosystems (e.g., tumor-targeting Pt nanosystems and anti-ROS nanosystems) have demonstrated to be effective in the prevention and treatment of PIPN
SURMOUNT-1 enrolled 2,539 adults with obesity or overweight
Each test typeurine, blood, hair, and salivahas unique methods and detection capabilities
They provide exceptional, fast service at a fair price
Short-acting GLP-1 receptor agonists such as exenatide immediate-release (Byetta) and lixisenatide (Adlyxin) must be administered within 60 minutes before meals